Literature DB >> 8872368

M1 and M3 muscarinic receptors in human pulmonary arteries.

X Norel1, L Walch, M Costantino, C Labat, I Gorenne, E Dulmet, F Rossi, C Brink.   

Abstract

1. Acetylcholine (ACh) and the M1 agonists (McN-A-343 or PD142505) relaxed human isolated pulmonary arteries which were pre-contracted with noradrenaline (10 microM). In preparations where the endothelium had been removed ACh induced a contractile response whereas the M1 agonists (McN-A-343 or PD142505) had no effect. 2. ACh- and McN-A-343-induced relaxations were abolished after treatment of endothelium-intact preparations with the drug combination NG-nitro-L-arginine (L-NOARG: 0.1 mM) and indomethacin (1.7 microM). 3. The affinity (pKB value) for pirenzepine was higher in human pulmonary arteries when tissues were relaxed with McN-A-343 as compared with ACh (pKB values, 7.71 +/- 0.30 (n = 4) and 6.68 +/- 0.15 (n = 8), respectively). In addition, the affinity for pFHHSiD against McN-A-343- and ACh-induced relaxations was 6.86 +/- 0.13 (n = 3) and 7.35 +/- 0.11 (n = 9) respectively. 4. The low affinities for methoctramine in human isolated pulmonary arteries with the endothelium either intact or removed, suggested the lack of involvement of M2 and M4 receptors in the Ach responses. 5. Phenoxybenzamine (3 microM: 30 min) abolished both ACh contraction and relaxation in human pulmonary artery. The ACh contraction was present when the phenoxybenzamine treatment was preceded by incubation with pFHHSiD (2 microM) but not with pirenzepine (1 microM). In addition, the ACh relaxation was present when preparations were treated with either pFHHSiD (2 microM) or pirenzepine (1 microM), before exposure to phenoxybenzamine. 6. These results in human isolated pulmonary arteries support the notion that only M3 receptors, on smooth muscle, mediate the ACh-induced contraction whereas M3 and M1 receptors are involved in the endothelium-dependent ACh-induced relaxation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872368      PMCID: PMC1915724          DOI: 10.1111/j.1476-5381.1996.tb15688.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Selectivity of methoctramine for muscarinic receptors in porcine cerebral arteries.

Authors:  K J Van Charldorp; D Davidesko; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1988-05-20       Impact factor: 4.432

2.  Interaction of p-F-HHSiD (p-Fluoro-hexahydrosila-difenidol) at muscarinic receptors in guinea-pig trachea.

Authors:  R M Eglen; C M Cornett; R L Whiting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

3.  Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.

Authors:  S Bunting; R Gryglewski; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1976-12

4.  Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta.

Authors:  N Jaiswal; G Lambrecht; E Mutschler; R Tacke; K U Malik
Journal:  J Pharmacol Exp Ther       Date:  1991-09       Impact factor: 4.030

5.  Prostanoid mediation of pulmonary vascular response to acetylcholine in rabbits.

Authors:  H A el Kashef; J D Catravas
Journal:  Am J Physiol       Date:  1986-10

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro.

Authors:  R M Eglen; A D Michel; W W Montgomery; E A Kunysz; C A Machado; R L Whiting
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

8.  Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors.

Authors:  J L Ortiz; C Labat; X Norel; I Gorenne; J Verley; C Brink
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

9.  Muscarinic receptor subtype mediating vasodilation feline middle cerebral artery exhibits M3 pharmacology.

Authors:  F Dauphin; E Hamel
Journal:  Eur J Pharmacol       Date:  1990-03-20       Impact factor: 4.432

10.  Differential bronchial and pulmonary vascular responses to vagal stimulation in the pig.

Authors:  R Matran; K Alving; J M Lundberg
Journal:  Acta Physiol Scand       Date:  1991-12
View more
  13 in total

1.  Acetylcholine-induced vasoconstrictor response of coronary vessels in rats: a possible contribution of M2 muscarinic receptor activation.

Authors:  Y Nasa; H Kume; S Takeo
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

2.  Role of the M3 muscarinic acetylcholine receptor subtype in murine ophthalmic arteries after endothelial removal.

Authors:  Adrian Gericke; Andreas Steege; Caroline Manicam; Tobias Böhmer; Jürgen Wess; Norbert Pfeiffer
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

Review 3.  Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.

Authors:  Michael R Ruggieri; Alan S Braverman; Michel A Pontari
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

Review 4.  GPCRs in pulmonary arterial hypertension: tipping the balance.

Authors:  Jean Iyinikkel; Fiona Murray
Journal:  Br J Pharmacol       Date:  2018-04-17       Impact factor: 8.739

5.  Evidence for a M(1) muscarinic receptor on the endothelium of human pulmonary veins.

Authors:  L Walch; J P Gascard; E Dulmet; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

6.  Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein.

Authors:  Virginia Andrea Pujol Lereis; Francisco Javier Hita; Mauro Darío Gobbi; Marcela Gomez Verdi; María Cecilia Rodriguez; Rodolfo Pedro Rothlin
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

7.  Role of M1, M3, and M5 muscarinic acetylcholine receptors in cholinergic dilation of small arteries studied with gene-targeted mice.

Authors:  Adrian Gericke; Jan J Sniatecki; Veronique G A Mayer; Evgeny Goloborodko; Andreas Patzak; Jürgen Wess; Norbert Pfeiffer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

8.  Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone.

Authors:  Xavier Norel; Laurence Walch; Jean-Pierre Gascard; Vincent deMontpreville; Charles Brink
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

9.  Contribution of the M3 muscarinic receptors to the vasodilator response to acetylcholine in the human forearm vascular bed.

Authors:  Teresa M Attinà; James J Oliver; Lorenzo S Malatino; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2008-04-10       Impact factor: 4.335

10.  Muscarinic Receptor Activation Affects Pulmonary Artery Contractility in Sheep: The Impact of Maturation and Chronic Hypoxia on Endothelium-Dependent and Endothelium-Independent Function.

Authors:  Michael Giang; Demosthenes G Papamatheakis; Dan Nguyen; Ricardo Paez; Carla Blum Johnston; Joon Kim; Alexander Brunnell; Quintin Blood; Ravi Goyal; Lawrence D Longo; Sean M Wilson
Journal:  High Alt Med Biol       Date:  2016-06       Impact factor: 1.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.